Summary
No AI-generated drug-label content was provided to evaluate. The prompt includes meta-assessment text about support/verification and an unrelated nested object, but there are no concrete prescribing-information claims to score against the supplied FDA label excerpts.
Category Scores
Accurate Statements
Unsupported Statements
The excerpts you supplied are consistent with the FDA-approved label for midodrine hydrochloride tablets.
This is a conclusion without showing any direct mapping of specific label text/excerpts to the stated conclusion, so it cannot be verified as an accurate, label-aligned claim from the provided content.
Supported: yes; Contradicted: no; Mentioned: yes; Evidence Summary: The boxed warning and Section 1 explicitly state that midodrine’s indication is based primarily on a surrogate BP marker and that clinical benefits have not been verified/established.
These are broad meta conclusions. While the provided label excerpts in the prompt do contain such concepts, the audit cannot confirm the AI response being evaluated actually matches the FDA label because the 'AI-generated response' to be audited is not present (user message starts with []).
Unable to verify (Insufficient evidence) ... Missing key information required for audit ... Without that, a compliance determination cannot be made.
This statement contradicts the prior 'Supported: yes' meta conclusion within the prompt content itself, and it is not tied to a specific, provided AI-generated response claim set to evaluate.
Contradictions
Low
AI Statement
Supported: yes ... Versus later: Unable to verify (Insufficient evidence) ...
Label Reference
N/A (meta-level inconsistency within provided content; no single label claim to reference).
Important Omissions
No explicit AI-generated prescribing-information claims were provided for point-by-point comparison (the user content shows an empty list [] and then includes meta-level objects rather than a specific answer to audit).
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
No patient-facing dosing, contraindication, warning, or monitoring instructions were actually provided in the 'AI-generated response' content to assess for safety.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Not Applicable
Primary Issue
No substantive AI response content (claims to evaluate) was provided.
Suggested Improvement
Provide the exact AI-generated response text intended for auditing so claims can be matched against the supplied FDA label excerpts.